Incidence and Identification of Intrathecal Baclofen Catheter Malfunction

PM and R

Volumn 2, Issue 8, 2010, Pages 751-756

  Dvorak, Eric M ^a   McGuire, John R ^a   Nelson, Mary Elizabeth S ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; INDIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; CATHETER COMPLICATION; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; FEMALE; FLUOROSCOPY; HEALTH CARE COST; HUMAN; IMPLANTABLE PORT SYSTEM; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SPASTICITY; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; AGED; BACLOFEN; CATHETERS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EQUIPMENT FAILURE; FEMALE; HUMANS; INCIDENCE; INFANT; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; MALE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 77955657000     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2010.01.016     Document Type: Article

References (26)

1. Ordia J.I., Fischer E., Adamski E., Spatz E.L. Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. J Neurosurg 1996, 85:452-457.
2. Azouvi P., Mane M., Thiebaut J.B., Denys P., Remy-Neris O., Bussel B. Intrathecal baclofen administration for control of severe spinal spasticity: Functional improvement and long-term follow-up. Arch Phys Med Rehabil 1996, 77:35-39.
3. Stempien L., Tsai T. Intrathecal baclofen pump use for spasticity: A clinical survey. Am J Phys Med Rehabil 2000, 79:536-541.
4. Gooch J.L., Oberg W.A., Grams B., Ward L.A., Walker M.L. Complications of intrathecal baclofen pumps in children. Pediatr Neurosurg 2003, 39:1-6.
5. Plassat R., Perrouin Verbe B., et al. Treatment of spasticity with intrathecal baclofen administration: Long-term follow-up review of 40 patients. Spinal Cord 2004, 42:686-693.
6. Pak S., Jallo G.I., Biser A., Ziessman H.A. Indium-111 diethylene-triamine-pentaacetic acid scintigraphy in the evaluation of function and patency of baclofen intrathecal infusion systems. Neurosurg Focus 2007, 23(1):E17.
7. Breton F.L., Daviet J.C., Monteil J., et al. Radioisotopic control for baclofen pump catheter failure. Spinal Cord 2001, 39:283-285.
8. Hoving M.A., Smulders N.M., Abdul Fatah B., et al. The use of an Indium111 DTPA flow study in the evaluation of a lumbar swelling in a girl with a baclofen pump. Neuropediatrics 2006, 37:99-101.
9. O'Connell M., Wong T.Z., Forkheim K.E., Jain M., Shipes S.W., Fuchs H.E. Comparison of Tc99m-DTPA and Indium-111 DTPA studies of baclofen pump function. Clin Nucl Med 2004, 29:578-580.
10. Sorokin A., Annabi E., Yang W.C., Kaplan R. Subdural intrathecal catheter placement: Experience with two cases. Pain Phys 2008, 11(5):677-680.
11. Pasquier Y., Cahana A., Schnider A. Subdural catheter migration may lead to baclofen pump dysfunction. Spinal Cord 2003, 41:700-702.
12. Ngo K., McGuire J.R. Failure to identify intrathecal baclofen pump/catheter problems can lead to unnecessary healthcare costs: A case report [abstract]. PM&R 2009, 1:S122-S123.
13. Bardutzky J., Tronnier V., Schwab S., Meinck H.-M. Intrathecal baclofen for stiff-person syndrome: Life-threatening intermittent catheter leakage. Neurology 2003, 60:1976-1978.
14. Vender J.R., Hester S., Waller J., Rekito A., Lee M.R. Identification and management of intrathecal baclofen pump complications: A comparison of pediatric and adult patients. J Neurosurg Pediatr 2006, 104:9-15.
15. Francisco G.E., Saulino M.F., Yablon S.A., Turner M. Intrathecal baclofen therapy: An update. PM&R 2009, 1:852-858.
16. Albright A.L., Gilmartin R., Swift D., Krach L.E., Ivanhoe C.B., McLaughlin J.F. Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin. J Neurosurg 2003, 98:291-295.
17. Barnes M. An overview of the clinical management of spasticity. Upper Motor Neuron Syndrome and Spasticity 2008, 1-8. Cambridge University Press, New York. 2nd ed. M. Barnes, G. Johnson (Eds.).
18. Newman L.B., Arieff A.J., Wasserman R.R. Present status in the management of spasticity and spasm: Preliminary report. Arch Phys Med Rehabil 1954, 35:427-436.
19. Taha J., Favre J., Janszen M., Galarza M., Taha A. Correlation between withdrawal symptoms and medication pump residual volume in patients with implantable synchromed pumps. Neurosurgery 2004, 55:390-394.
20. Rigoli G., Terrini G., Cordioli Z. Intrathecal baclofen withdrawal syndrome caused by low residual volume in the pump reservoir: A report of 2 cases. Arch Phys Med Rehabil 2004, 85:2064-2066.
21. Li T.C., Chen M.H., Huang J.S., Chan J.Y., Liu Y.K., Chen M.H. Catheter migration after implantation of an intrathecal baclofen infusion pump for severe spasticity: A case report. Kaohsiung J Med Sci 2008, 24(9):492-497.
22. Schmidt E., Oates E. In-111 DTPA to evaluate the patency of an implanted intrathecal infusion pump. Clin Nucl Med 1997, 22(11):768-770.
23. Stinchon J.F., Shah N.P., Ordia J., Oates E. Scintigraphic evaluation of intrathecal infusion systems: Selection of patients for surgical or medical management. Clin Nucl Med 2006, 31:1-4.
24. Stokic D.S., Yablon S.A., Hayes A., Vesovic-Potic V., Olivier J. Dose-response relationship between the H-reflex and continuous intrathecal baclofen administration for management of spasticity. Clin Neurophysiol 2006, 117:1283-1289.
25. Yablon S.A., Stokic D.S. Neurophysiologic evaluation of spastic hypertonia: Implications for management of the patient with the intrathecal baclofen pump. Am J Phys Med Rehabil 2004, 83(suppl):S10-S18.
26. Stokic D.S., Yablon S.A. Neurophysiological basis and clinical applications of the H-reflex as an adjunct for evaluating response to intrathecal baclofen for spasticity. Acta Neurochir Suppl 2007, 97:231-241.